Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomea Fusion, Inc.

1.91
-0.9900-34.14%
Post-market: 1.940.0300+1.57%19:59 EDT
Volume:11.66M
Turnover:23.43M
Market Cap:71.76M
PE:-0.54
High:2.23
Open:2.06
Low:1.84
Close:2.90
Loading ...

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
24 Mar

Biomea Fusion Inc - Icovamenib Shows Sustained Reduction in Hba1c and Beta-Cell Function

THOMSON REUTERS
·
24 Mar

Biomea Fusion Inc - Icovamenib Enhances Impact of Glp-1 Based Therapeutic Agents

THOMSON REUTERS
·
24 Mar

Icovamenib Treatment in Patients With Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-Cell Function With a 53% Mean Increase in C-Peptide Levels 3 Months After Last Dose

THOMSON REUTERS
·
24 Mar

Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose

GlobeNewswire
·
24 Mar

Biomea Fusion Insiders Recover Some Losses, Which Stand At US$91k

Simply Wall St.
·
22 Mar

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
19 Mar

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Mar

Biomea Fusion CFO Franco Valle Resigns

TIPRANKS
·
01 Mar

BRIEF-Biomea Fusion Says Franco Valle Resigns As CFO

Reuters
·
01 Mar

Biomea Fusion Inc - Franco Valle Resigns as CFO of Biomea Fusion

THOMSON REUTERS
·
01 Mar

Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes

GlobeNewswire
·
27 Feb

Promising US Penny Stocks To Watch In February 2025

Simply Wall St.
·
19 Feb

Insider Buyers Lose Additional US$78k As Biomea Fusion Dips To US$126m

Simply Wall St.
·
13 Feb

Biomea Fusion, Inc. (NASDAQ:BMEA) is a favorite amongst institutional investors who own 51%

Simply Wall St.
·
05 Feb

Biomea Fusion Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Jan

Biomea Fusion’s Strategic Focus on Metabolic Diseases and Promising Pipeline Advances Garner Buy Rating

TIPRANKS
·
14 Jan

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
14 Jan

Biomea Fusion price target lowered to $16 from $128 at D. Boral Capital

TIPRANKS
·
13 Jan